Citigroup’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-29,900
Closed -$996K 5694
2024
Q4
$996K Sell
29,900
-71,000
-70% -$2.3M ﹤0.01% 3372
2024
Q3
$2.62M Buy
100,900
+71,000
+237% +$1.76M ﹤0.01% 2429
2024
Q2
$672K Hold
29,900
﹤0.01% 3197
2024
Q1
$710K Buy
+29,900
New +$665K ﹤0.01% 3303
2021
Q1
Sell
-12,800
Closed -$257K 6597
2020
Q4
$257K Sell
12,800
-6,600
-34% -$138K ﹤0.01% 4796
2020
Q3
$474K Sell
19,400
-12,800
-40% -$299K ﹤0.01% 3891
2020
Q2
$764K Sell
32,200
-45,700
-59% -$1.06M ﹤0.01% 3836
2020
Q1
$1.34M Buy
77,900
+2,200
+3% +$40.2K ﹤0.01% 2869
2019
Q4
$1.33M Sell
75,700
-30,300
-29% -$514K ﹤0.01% 3444
2019
Q3
$1.88M Buy
106,000
+14,900
+16% +$302K ﹤0.01% 2944
2019
Q2
$1.95M Buy
91,100
+21,500
+31% +$451K ﹤0.01% 2889
2019
Q1
$1.66M Buy
69,600
+27,800
+67% +$634K ﹤0.01% 2859
2018
Q4
$822K Sell
41,800
-16,300
-28% -$291K ﹤0.01% 3599
2018
Q3
$1.03M Buy
58,100
+21,100
+57% +$411K ﹤0.01% 3473
2018
Q2
$796K Sell
37,000
-32,000
-46% -$662K ﹤0.01% 3605
2018
Q1
$1.53M Sell
69,000
-7,200
-9% -$199K ﹤0.01% 2849
2017
Q4
$2.32M Buy
76,200
+2,800
+4% +$74.5K ﹤0.01% 2523
2017
Q3
$1.78M Buy
73,400
+17,300
+31% +$460K ﹤0.01% 2779
2017
Q2
$1.38M Sell
56,100
-4,400
-7% -$93.1K ﹤0.01% 2968
2017
Q1
$1.31M Buy
60,500
+22,000
+57% +$447K ﹤0.01% 2927
2016
Q4
$574K Buy
38,500
+11,100
+41% +$160K ﹤0.01% 4233
2016
Q3
$350K Sell
27,400
-900
-3% -$9.73K ﹤0.01% 4222
2016
Q2
$221K Buy
28,300
+14,800
+110% +$85.3K ﹤0.01% 4401
2016
Q1
$54K Sell
13,500
-3,500
-21% -$14.8K ﹤0.01% 6077
2015
Q4
$96K Buy
17,000
+10,500
+162% +$58.8K ﹤0.01% 5402
2015
Q3
$36K Sell
6,500
-495,800
-99% -$2.7M ﹤0.01% 5638
2015
Q2
$1.89M Buy
+502,300
New +$1.63M ﹤0.01% 2575

Other funds holding EXEL

Citigroup's EXEL Position: Q1 2026 in Review

Citigroup reduced its Exelixis (EXEL) stake by 3.3% in Q1 2026, selling an estimated $220K and leaving 149,846 shares worth $6.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

Citigroup first reported a position in EXEL in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.7M in Q2 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Citigroup held 149,846 shares of Exelixis worth $6.43M as of Q1 2026.
  • Citigroup sold 5,125 Exelixis shares in Q1 2026, an estimated $220K.
  • Exelixis made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #1774 holding.
  • Citigroup first reported a position in Exelixis in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Exelixis position peaked at $30.7M in Q2 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.